Mucin Transiently Sustains Coronavirus Infectivity through Heterogenous Changes in Phase Morphology of Evaporating

Robert W Alexander1, Jianghan Tian2, Allen E Haddrell2

  • 1School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.

Viruses
|September 23, 2022
PubMed

Insights

Mucus can temporarily protect airborne respiratory viruses like mouse hepatitis virus (MHV) and SARS-CoV-2 from losing infectivity. This finding highlights mucus

Area of Science:

  • Aerosol science
  • Virology
  • Respiratory pathogen transmission

Background:

  • Respiratory pathogens spread via aerosolized droplets and particulates.
  • Understanding airborne survival mechanisms is key to controlling dissemination.
  • Previous studies examined SARS-CoV-2 airborne stability.

Purpose of the Study:

  • To investigate the airborne survival of mouse hepatitis virus (MHV).
  • To compare MHV airborne infectivity loss with SARS-CoV-2.
  • To assess the impact of mucin on viral viability in aerosols.

Main Methods:

  • Utilized Controlled Electrodynamic Levitation and Extraction of Bioaerosol onto Substrate (CELEBS).
  • Employed comparative kinetics electrodynamic balance (CKEDB) for measurements.
  • Measured viral viability and aerosol evaporation kinetics with high time resolution.

Main Results:

  • MHV showed a comparable loss of infectivity in aerosols to SARS-CoV-2.
  • Mucin addition transiently mitigated infectivity loss at 40% relative humidity.
  • Higher mucin concentrations induced heterogeneous phase changes and inclusions in droplets.

Conclusions:

  • Mucus plays a role in the aerosol phase, influencing short-term viral stability.
  • Mucin's protective effect is linked to altered aerosol evaporation dynamics.
  • Findings provide insights into pathogen transmission dynamics and control strategies.